| Literature DB >> 34830352 |
Snježana Radulović1, Sowmya Sunkara1, Christa Maurer2, Gerd Leitinger1.
Abstract
Recent research has provided strong evidence that neurodegeneration may develop from an imbalance between synaptic structural components in the brain. Lately, inhibitory synapses communicating via the neurotransmitters GABA or glycine have come to the center of attention. Increasing evidence suggests that imbalance in the structural composition of inhibitory synapses affect deeply the ability of neurons to communicate effectively over synaptic connections. Progressive failure of synaptic plasticity and memory are thus hallmarks of neurodegenerative diseases. In order to prove that structural changes at synapses contribute to neurodegeneration, we need to visualize single-molecule interactions at synaptic sites in an exact spatial and time frame. This visualization has been restricted in terms of spatial and temporal resolution. New developments in electron microscopy and super-resolution microscopy have improved spatial and time resolution tremendously, opening up numerous possibilities. Here we critically review current and recently developed methods for high-resolution visualization of inhibitory synapses in the context of neurodegenerative diseases. We present advantages, strengths, weaknesses, and current limitations for selected methods in research, as well as present a future perspective. A range of new options has become available that will soon help understand the involvement of inhibitory synapses in neurodegenerative disorders.Entities:
Keywords: Alzheimer’s disease; EM; SIM; STED; STORM; inhibitory synapse; neurodegeneration; synaptic plasticity
Mesh:
Substances:
Year: 2021 PMID: 34830352 PMCID: PMC8623765 DOI: 10.3390/ijms222212470
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Schematic representation of the direct and indirect influence of amyloid-beta oligomers (AβO), hyperphosphorylated tau (hTau), and neurofibrillary tangles (NFT) on synaptic components in the context of Alzheimer’s disease (AD). The figure represents an example of the influence of protein aggregates and biomarkers on synaptic plasticity at functional and molecular levels in neurodegenerative diseases, which affects the cognitive functions of the brain. α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) and N-methyl D-aspartate Receptors (NMDAR) are glutamate receptors present on the postsynaptic membrane. GABAAR—γ-aminobutyric acid type-B receptors; APP—amyloid-beta precursor protein; Ca2+—calcium ion; ROS—reactive oxygen species; ATP—adenosine triphosphate; cyt c—cytochrome c; VAMP 2—Vesicle-associated membrane protein 2; NT—neurotransmitter [3,10,11,12,13,14,15,16,17,18,19,20,21].
The most common neurodegenerative diseases and their specific effect on inhibitory synapses (IS). The current treatment options and drugs mentioned here are used only to alleviate the symptoms in order to halt the progression of the disease.
| Type | Profile | Major Symptoms | Impact on IS | Treatment | Drug Target Site | Reference |
|---|---|---|---|---|---|---|
| Alzheimer’s disease | MRI | Dementia cognitive impairment | Loss of GABAergic neurons | Memantine | NMDAR | [ |
| Parkinson’s disease | MRI | Dementia Bradykinesia Rigidity Rest tremors | Loss of dopaminergic neurons | Levodopa combined with dopamine agonists | Presynaptic nerve terminals | [ |
| Multiple Sclerosis | MRI | cognitive impairment defects in vision muscle spasms fatigue | loss of motor neurons loss of selective inhibitory neurons | Immunosuppressants Cytokines | Myelin sheath Axon fibers | [ |
| Amyotrophic Lateral Sclerosis | Neurofilaments | cognitive impairment frontotemporal dementia muscle spasms and atrophy | loss of inhibitory cortical interneurons | Riluzole Baclofen | blocks NMDAR–postsynapse inhibits glutamate release—pre-synapse GABABR agonist–postsynapse | [ |
| Huntington’s disease | MRI | cognitive impairment dementia chorea | loss of GABAAR | Tetrabenazine Antipsychotics | inhibits VMAT-2—presynapse | [ |
Abbreviations: EN—excitatory neurons; IN—inhibitory neurons; MRI—Magnetic Resonance Imaging; NFT—Neurofibrillary tangles, hTau—hyperphosphorylated tau; GABA—Gamma Amino Butyric Acid; NMDAR—N-methyl D-aspartate Receptors; GABAAR—γ-aminobutyric acid type-A receptors; GABABR—γ-aminobutyric acid type-B receptors; mHTT—mutant Huntington’s protein; VMAT—vesicular monoamine transporter.
Figure 2Conventional electron microscopy allows visualizing synapses and analytical electron microscopy allows visualizing iron-loaded ferritin. (A): Conventional electron micrograph of a synapse in a human cortex sample. Synaptic vesicles (SV), postsynaptic density (PD). (B,C): Conventional electron micrograph (B), and corresponding iron L-map (C) from a sample of the human globus pallidus. The bright spots in (C) correspond to ferritin particles within an oligodendrocyte (O). AX—axon; MS—myelin sheath.
Comparison of technical performances of most commonly used super-resolution methods.
| SIM | STED | PALM/STORM | |
|---|---|---|---|
| Resolution | x/y = 60–140 nm | x/y = 2–40 nm | x/y = 1–40 nm |
| Live imaging | 240 fr/s Lattice SIM, Zeiss | 10–20 fr/s depending on area | 0.2 fr/s |
| Laser power | 1–10 W/cm2 | 100 MW/cm2 | 1–25 kW/cm2 |
| Colours | 4 | Max 2 | 2–4 |
| Dyes | typical fluorescent dyes | Atto647N, Chromeo 494 | AF647, mEos2 |
Figure 3Guidelines for choosing appropriate visualization methods (SIM—structured illumination microscopy; PALM—photo-activated localization microscopy; STED—stimulated emission depletion microscopy; STORM—stochastic optical reconstruction microscopy; EM—electron microscopy; TEM—transmission electron microscopy).